Risk of infections in psoriasis: assessment and challenges in daily management.
Clara De SimoneMaria Concetta FargnoliPaolo AmerioLuca BianchiMaria EspositoFederico PirroConcetta PotenzaFederica RicceriFranco RongiolettiLuca StingeniFrancesca PrignanoPublished in: Expert review of clinical immunology (2021)
In this perspective, the current knowledge on the infectious risk in psoriatic patient, related to comorbidities, such as diabetes mellitus, cardiovascular disease, and chronic obstructive pulmonary, to 'special populations,' to chronic infections, such as latent tuberculosis, chronic hepatitis B and C, and HIV, and to the most recent Covid-19 pandemic scenario, is reviewed and discussed in order to suggest the most appropriate approach and achieve the best available therapeutic option.
Keyphrases
- cardiovascular disease
- hiv aids
- antiretroviral therapy
- healthcare
- hiv positive
- hiv infected
- pulmonary hypertension
- human immunodeficiency virus
- mycobacterium tuberculosis
- rheumatoid arthritis
- hepatitis c virus
- case report
- drug induced
- physical activity
- hiv testing
- adipose tissue
- pulmonary tuberculosis
- coronary artery disease
- disease activity
- south africa
- insulin resistance
- skeletal muscle
- systemic lupus erythematosus
- liver fibrosis